LYVE1 is a Link domain-containing hyaladherin, which means it has a domain that allows it to bind to hyaluronic acid . It is homologous to CD44, the main HA receptor . LYVE1 acts as a receptor and binds to both soluble and immobilized hyaluronan . This protein may function in lymphatic hyaluronan transport and have a role in tumor metastasis .
LYVE1 is primarily expressed on the surface of lymphatic endothelial cells, making it a useful marker for these cells . However, its expression is not restricted to lymphatic vessels. It is also observed in normal liver blood sinusoids and embryonic blood vessels . Additionally, LYVE1 expression is found in a subset of macrophages, including those in the meninges of rats .
The physiological role of LYVE1 is still under investigation, but its evolutionary conservation suggests it plays an important role . It is involved in the hyaluronan catabolic process, cell adhesion, and signal transduction . LYVE1 may act as a hyaluronan transporter, mediating its uptake for catabolism within lymphatic endothelial cells or its transport into the lumen of afferent lymphatic vessels for subsequent re-uptake and degradation in lymph nodes .
LYVE1 has been implicated in various pathological conditions. It may have a role in tumor metastasis due to its involvement in lymphatic hyaluronan transport . Additionally, LYVE1+ macrophages have been observed in the synovium of patients with rheumatoid arthritis, suggesting a role in inflammatory processes .